首页> 外国专利> Therapeutic drugs and therapeutic methods involving 1,25D3-MARRS for neurological diseases including Alzheimer's disease, etc.

Therapeutic drugs and therapeutic methods involving 1,25D3-MARRS for neurological diseases including Alzheimer's disease, etc.

机译:1,25D3-MARRS涉及的神经疾病,包括阿尔茨海默氏病等的治疗药物和治疗方法。

摘要

Providing fundamental therapeutic agents based on the pathogenesis mechanism of diseases related to nerve axon dysfunction (for example, Alzheimer's disease, dementia, Parkinson's disease, spinal cord injury, cerebral contusion, etc.) The main issue. Provided is a compound having a stimulating activity of 1,25D3-MARRS, or a salt thereof. Furthermore, the present invention provides a technical concept relating to a pharmaceutical composition, a production method, a method for preventing or treating a disease, and a kit containing the therapeutically effective amount.
机译:基于与神经轴突功能障碍相关的疾病(例如,阿尔茨海默氏病,痴呆,帕金森氏病,脊髓损伤,脑挫裂伤等)的发病机理提供基本的治疗药物。提供具有1,25D3-MARRS的刺激活性的化合物或其盐。此外,本发明提供了与药物组合物,生产方法,用于预防或治疗疾病的方法以及包含治疗有效量的试剂盒有关的技术概念。

著录项

  • 公开/公告号JPWO2014112145A1

    专利类型

  • 公开/公告日2017-01-19

    原文格式PDF

  • 申请/专利权人 レジリオ株式会社;

    申请/专利号JP20140514252

  • 发明设计人 東田 千尋;

    申请日2013-07-24

  • 分类号A61K45;A61K31/58;A61K45/06;A61P25/28;A61P43;A61P25;A61P25/16;

  • 国家 JP

  • 入库时间 2022-08-21 13:53:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号